The in vivo proconvulsant effects of corticotropin releasing hormone in the developing rat are independent of ionotropic glutamate receptor activation

Developmental Brain Research

Volumn 111, Issue 1, 1998, Pages 119-128

  Brunson, Kristen L ^a   Schultz, Linda ^a   Baram, Tallie Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corticotropin releasing hormone; Glutamate receptors; Rat; Seizure

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DIZOCILPINE; GLUTAMATE RECEPTOR ANTAGONIST; IONOTROPIC RECEPTOR; KAINIC ACID; KAINIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; KINDLING; LATENT PERIOD; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SEIZURE SUSCEPTIBILITY; SEIZURE THRESHOLD;

AGING; ANIMALS; ANIMALS, NEWBORN; CORTICOTROPIN-RELEASING HORMONE; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ELECTROENCEPHALOGRAPHY; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HORMONE ANTAGONISTS; KAINIC ACID; KINDLING, NEUROLOGIC; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUTAMATE; SEIZURES;

EID: 0032213144     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00130-8     Document Type: Article

References (48)

1. Albala B.J., Moshe S.L., Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res. 315:1984;139-148.
2. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., Siggins G.R. Corticotropin releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science. 221:1983;875-877.
3. Avishai-Eliner S., Yi S.J., Baram T.Z. Developmental profile of messenger RNA for the corticotropin-releasing hormone receptor in the rat limbic system. Dev. Brain Res. 91:1996;159-163.
4. 1 receptor mediates the excitatory actions of corticotropin releasing factor in the developing rat brain: in vivo evidence using novel, selective, non-peptide CRF receptor antagonists. Brain Res. 770:1997;89-95.
5. Baram T.Z., Hatalski C.G. Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends in Neurosci. 21:1998;471-476.
6. Baram T.Z., Hirsch E. EEG recording in neonatal and infant rats: some pitfalls and solutions. Dendron. 1:1992;39-46.
7. Baram T.Z., Hirsch E., Schultz L. Short-interval amygdala kindling in neonatal rats. Dev. Brain Res. 73:1993;79-83.
8. Baram T.Z., Hirsch E., Snead O.C., Schultz L. Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann. Neurol. 31:1992;488-494.
9. Baram T.Z., Ribak C.E. Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. NeuroReport. 6:1995;277-280.
10. Baram T.Z., Schultz L. Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Dev. Brain Res. 61:1991;97-101.
11. Berg A.T., Shinnar S., Shapiro E.D., Salomon M.E., Crain E.F., Hauser W.A. Risk factors for a first febrile seizure: a matched case-control study. Epilepsia. 36:1995;334-341.
12. Chang D., Baram T.Z. Status epilepticus results in reversible neuronal injury in infant rat hippocampus: novel use of a marker. Dev. Brain Res. 77:1994;133-136.
13. Cherubini E., De Feo M.R., Mecarelli O., Ricci G.F. Behavioral and electrographic patterns induced by systemic administration of kainic acid in developing rats. Brain Res. 285:1983;69-77.
14. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat CNS: an autoradiographic study. J. Neurosci. 5:1985;3189-3203.
15. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W., Bloom F.E. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res. 278:1983;332-336.
16. Fariello R.G., Golden G.T., Smith G.G., Reyes P.F. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist. Epilepsy Res. 3:1989;206-213.
17. Gray T.S., Bingaman E.W. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit. Rev. Neurobiol. 10:1996;155-168.
18. Haas K.Z., Sperber E.F., Moshe S.L. Kindling in developing animals: expression of severe seizures and enhanced development of bilateral foci. Dev. Brain Res. 56:1990;275-280.
19. C.G. Hatalski, C. Guirguis, T.Z. Baram, Corticotropin releasing factor mRNA expression in the hypothalamic paraventricular nucleus and the central nucleus of the amygdala is modulated by repeated acute stress in the immature rat, J. Neuroendocrinol. (1998), in press.
20. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia. 35:1994;S1-S6. Suppl. 2.
21. Hollrigel G.S., Chen K., Baram T.Z., Soltesz I. The pro-convulsant actions of corticotropin-releasing hormone in the hippocampus of infant rats. Neuroscience. 84:1998;71-79.
22. Holmes G.L. Epilepsy in the developing brain: lessons from the laboratory and clinic. Epilepsia. 38:1997;12-30.
23. Holmes G.L., Thompson J.L. Effects of kainic acid on seizure susceptibility in the developing brain. Brain Res. 467:1988;51-59.
24. Holmes G.L., Werner S., Liu Z., Carmant L., Mikati M. Adverse effects of excitatory amino acid antagonists on the developing brain. Ann. Neurol. 36:1994;494.
25. Holmes K.H., Bilkey D.K., Laverty R., Goddard G.V. The N-methyl-D-aspartate antagonists aminophosphonovalerate and carboxypiperazinephosphonate retard the development and expression of kindled seizures. Brain Res. 506:1990;227-235.
26. Insel T.R., Battaglia G., Fairbanks D.W., De Souza E.B. The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase. J. Neurosci. 8:1988;4151-4158.
27. Jensen F.E., Blume H., Alvarado S., Firkusny I., Geary C. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia. 36:1995;966-972.
28. Lothman E.W., Collins R.C. Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res. 218:1981;299-318.
29. Lyons M.K., Anderson R.E., Meyer F.B. Corticotropin releasing factor antagonist reduces ischemic hippocampal neuronal injury. Brain Res. 545:1991;339-342.
30. Maecker H., Desai A., Dash R., Rivier J., Vale W., Sapolsky R. Astressin, a novel and potent CRF antagonist, is neuroprotective in the hippocampus when administered after a seizure. Brain Res. 744:1997;166-170.
31. Marrosu F., Fratta W., Carcangiu P., Giagheddu M., Gessa G.L. Localized epileptiform activity induced by murine CRF in rats. Epilepsia. 29:1988;369-373.
32. Meldrum B.S., Craggs M.D., Durmuller N., Smith S.E., Chapman A.G. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res. Suppl. 9:1992;307-311.
33. Morimoto K., Holmes K.H., Goddard G.V. Kindling-induced changes in EEG recorded during stimulation from the site of stimulation: III. Direct pharmacological manipulations of the kindled amygdala. Exp. Neurol. 97:1987;17-34.
34. Morimoto T., Kida K., Nagao H., Yoshida K., Fukuda M., Takashima S. The pathogenic role of the NMDA receptor in hyperthermia-induced seizures in developing rats. Dev. Brain Res. 84:1995;204-207.
35. Oliverio A., Castellano C., Puglisi-Allegra S., Renzi P. Diurnal variations in electroconvulsive shock-induced seizures: involvement of endogenous opioids. Neurosci. Lett. 57:1985;237-240.
36. Olney J.W. Excitotoxic amino acids and neuropsychiatric disorders. Annu. Rev. Pharmacol. Toxicol. 30:1990;47-71.
37. N.M. Sherwood, P.S. Timiras, A Stereotaxic Atlas of the Developing Rat Brain, University of California Press, Berkeley, 1970.
38. S. Shinnar, S.L. Moshe, Age specificity of seizure expression in genetic epilepsies, in: V.E. Anderson, W.A. Hauser, I.E. Leppik, J.L. Noebels, S.S. Rich (Eds.), Genetic Strategies in Epilepsy Research, Epilepsy Res. Suppl. 4, Elsevier (1991) 69-85.
39. Smith B.N., Dudek F.E. Age-related epileptogenic effects of corticotropin-releasing hormone in the isolated CA1 region of rat hippocampal slices. J. Neurophysiol. 72:1994;2328-2333.
40. Stafstrom C.E., Tandon P., Hori A., Liu Z., Mikati M.A., Holmes G.L. Acute effects of MK-801 on kainic acid-induced seizures in neonatal rats. Epilepsy Res. 26:1997;335-344.
41. Strijbos P.J., Relton J.K., Rothwell N.J. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res. 656:1994;405-408.
42. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology. 36:1983;165-186.
43. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
44. Virgili M., Migani P., Contestabile A., Barnabei O. Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers. Neuropharmacology. 31:1992;469-474.
45. Watts A.G., Swanson L.W. Diurnal variations in the content of preprocorticotropin-releasing hormone messenger ribonucleic acids in the hypothalamic paraventricular nucleus of rats of both sexes as measured by in situ hybridization. Endocrinology. 125:1989;1734-1738.
46. Weiss G.K., Castillo N., Fernandez M. Amygdala kindling rate is altered in rats with a deficit in the responsiveness of the hypothalamo-pituitary-adrenal axis. Neurosci. Lett. 157:1993;91-94.
47. Weiss S.R., Post R.M., Gold P.W., Chrousos G., Sullivan T.L., Walker D., Pert A. CRF-induced seizures and behavior: interaction with amygdala kindling. Brain Res. 372:1986;345-351.
48. Wozniak D.F., Olney J.W., Kettinger L. III, Price M., Miller J.P. Behavioral effects of MK-801 in the rat. Psychopharmacology. 101:1990;47-56.